Crossmark

Serious adverse events in African–American cancer patients with sickle cell trait and inherited haemoglobinopathies in a SEER-Medicare claims cohort

Crossref DOI link: https://doi.org/10.1038/s41416-019-0416-7

Published Online: 2019-03-20

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hoag, Jessica R.

Andemariam, Biree

Wang, Xiaoyan

Gregorio, David I.

Jones, Beth A.

Sporn, Jonathan

Salner, Andrew L.

Swede, Helen https://orcid.org/0000-0002-6707-7964
Funding

Funding for this research was provided by:

Connecticut Breast Health Initiative

Connecticut Institute for Clinical and Translational Sciences
License Information

Text and Data Mining valid from 2019-03-20
More Information

Article History

Received: 20 July 2018

Revised: 4 February 2019

Accepted: 12 February 2019

First Online: 20 March 2019

Competing interests

: The authors declare no competing interests.

: The UConn Institutional Review Board approved this study as exempt from review as a secondary analysis of publicly available de-identified data.

: SEER-Medicare database is publicly available

: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).